Free Opening Brief in Support - District Court of Delaware - Delaware

Case 1:06-cv-00774-JJF

Document 217

Filed 04/04/2008

Page 1 of 12

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE RELIANT PHARMACEUTICALS, INC., Plaintiff, v. PAR PHARMACEUTICAL, INC., Defendant. ) ) ) ) ) ) ) )

C.A. No. 06-774 (JJF)

RELIANT PHARMACEUTICALS, INC.'S OPENING BRIEF IN SUPPORT OF ITS MOTION TO COMPEL PAR PHARMACEUTICAL, INC. TO SUPPLEMENT ITS INTERROGATORY RESPONSES

MORRIS, NICHOLS, ARSHT & TUNNELL LLP Jack B. Blumenfeld (#1014) Maryellen Noreika (#3208) 1201 North Market Street P.O. Box 1347 Wilmington, DE 19899-1347 (302) 658-9200 [email protected] [email protected] Attorneys for Plaintiff OF COUNSEL: John M. Desmarais Gerald J. Flattmann, Jr. Christine Willgoos KIRKLAND & ELLIS LLP Citigroup Center 153 E. 53rd Street New York, NY 10022 (212) 446-4800 April 4, 2008

Case 1:06-cv-00774-JJF

Document 217

Filed 04/04/2008

Page 2 of 12 i.

TABLE OF CONTENTS Page TABLE OF AUTHORITIES ............................................................................................................. NATURE AND STAGE OF THE PROCEEDINGS ......................................................................1 SUMMARY OF THE ARGUMENT ..............................................................................................1 STATEMENT OF FACTS ..............................................................................................................2 ARGUMENT...................................................................................................................................2 A. B. C. Legal Standard .............................................................................................2 Par Should Be Ordered to Supplement Its Responses to Interrogatories 9-11, 13, and 15-18..............................................................3 Par Should Be Ordered to Supplement Its Responses to Interrogatories 7 and 12 ...............................................................................7

CONCLUSION................................................................................................................................8

Case 1:06-cv-00774-JJF

Document 217

Filed 04/04/2008

Page 3 of 12 ii.

TABLE OF AUTHORITIES Page(s) CASES In re G-I Holdings Inc., 218 F.R.D. 428 (D.N.J. 2003)....................................................................................................2 Power Integrations, Inc. v. Fairchild Semiconductor Int'l, Inc., No. 04-1371-JJF, 2005 WL 5949576 (D.Del. 2005) .................................................................2 STATUTES AND RULES 21 U.S.C. § 355(j)(2)(A)(vii)(IV) ....................................................................................................1 Fed. R. Civ. P. 26.........................................................................................................................2, 3 Fed. R. Civ. P. 33.........................................................................................................................2, 7 Fed. R. Civ. P. 37(a)(3)(B) ..............................................................................................................3 OTHER AUTHORITIES Charles Alan Wright & Arthur R. Miller, Federal Practice & Procedure § 2177 (2008)..............2

Case 1:06-cv-00774-JJF

Document 217

Filed 04/04/2008

Page 4 of 12 1.

NATURE AND STAGE OF THE PROCEEDINGS On December 19, 2006, Reliant Pharmaceuticals, Inc. ("Reliant") filed this action for infringement of U.S. Patent No. 5,681,588 ("the `588 patent") against Par Pharmaceutical, Inc. ("Par"), based on Par's filing of ANDA 78-540 and associated certification pursuant to 21 U.S.C. § 355(j)(2)(A)(vii)(IV), by which it seeks to market generic versions of Reliant's drug Rythmol® SR. D.I. 1. Par answered Reliant's Complaint on February 9, 2007. D.I. 11. This action is nearing the end of fact discovery. To date, both parties have produced hard-copy and electronic documents. On March 14, 2008, the parties exchanged logs of privileged documents. The parties have taken multiple depositions during the months of February and March, and have several remaining depositions scheduled for the month of April. The fact discovery period is set to end on April 7, 2008. D.I. 200. Reliant has moved to compel Par to supplement its interrogatory responses. This is Reliant's opening brief in support of that motion. SUMMARY OF THE ARGUMENT Par has failed to meet its discovery obligations with respect to ten of Reliant's interrogatories. Par's responses to Interrogatory Nos. 9-11, 13, and 15-18 were cursory and evasive. Par's responses to Interrogatory Nos. 7 and 12 failed to identify opinions of counsel in its privilege log or affirm that no such opinions exist. None of Par's responses to the abovementioned interrogatories were sufficient under the Federal Rules of Civil Procedure. Therefore, Reliant requests that the Court order Par to supplement its responses to Reliant Interrogatory Nos. 7, 9-13, and 15-18.

Case 1:06-cv-00774-JJF

Document 217

Filed 04/04/2008

Page 5 of 12 2.

STATEMENT OF FACTS Reliant served its First Set Of Interrogatories (Nos. 1-18) on May 18, 2007. See Ex. A. Par responded on June 18. See Ex. B. Several of Par's responses to these interrogatories lacked any substantive response. On March 26, 2008, Reliant requested that Par supplement its responses to Interrogatories Nos. 7, 9-13, and 15-18. See Ex. C. Par has not done so. ARGUMENT A. Legal Standard

"The Federal Rules of Civil Procedure allow for broad and liberal discovery." Power Integrations, Inc. v. Fairchild Semiconductor Int'l, Inc., No. 04-1371-JJF, 2005 WL 5949576, at *2 (D.Del. 2005) (internal citation omitted); see also Fed. R. Civ. P. 26(b) (discovery may include "any nonprivileged matter that is relevant to any party's claim or defense . . . ."). With respect to interrogatories, "[e]ach interrogatory must, to the extent it is not objected to, be answered separately and fully in writing under oath." Fed. R. Civ. P. 33(b)(3) (emphasis added). Answers must be responsive, full, complete and unevasive. Insofar as practical they should be complete within themselves. Material outside the answers and their addendum ordinarily should not be incorporated by reference. If information from other answers is incorporated in a particular answer to avoid repetition, references should be specific rather than general. 8A Charles Alan Wright & Arthur R. Miller, Federal Practice & Procedure § 2177 (2008) (quoting Pilling v. General Motors Corp., 45 F.R.D. 366, 369 (D. Utah 1968)); see also In re G-I Holdings Inc., 218 F.R.D. 428, 438 (D.N.J. 2003). A party's obligations do not end once it has provided a response. A party . . . who has responded to an interrogatory . . . must supplement or correct its disclosure or response:

Case 1:06-cv-00774-JJF

Document 217

Filed 04/04/2008

Page 6 of 12 3.

(A) in a timely manner if the party learns that in some material respect the disclosure or response is incomplete or incorrect, and if the additional or corrective information has not otherwise been made known to the other parties during the discovery process or in writing; or (B) as ordered by the court. Fed. R. Civ. P. 26(e). If a party fails to answer an interrogatory, "[the] party seeking discovery may move for an order compelling an answer . . . ." Fed. R. Civ. P. 37(a)(3)(B). Par's cursory responses to ten of Reliant's interrogatories were insufficient to satisfy Par's obligations. Despite its awareness that these responses were incomplete, Par never supplemented its responses as required by Rule 26 nor indicated any intent to do so. Par has ignored Reliant's request for supplementation. B. Par Should Be Ordered to Supplement Its Responses to Interrogatories 9-11, 13, and 15-18

Reliant Interrogatory Nos. 9-11, 13, and 15-18 seek information regarding Par's product development, its ANDA preparation and filings, its sales projections, its product testing, and its manufacturing processes. All of these interrogatories relate to Par's proposed generic drug and its infringement of Reliant's `588 Patent. Par's responses to these interrogatories are substantially the same: Par makes numerous objections and an equivocal identification of two "persons who may have knowledge or information concerning the inquired-about topics." Ex. B passim (emphasis added). But none of Par's "responses" to Interrogatory Nos. 9-11, 13, and 1518 contains any additional information beyond these objections and tentative identifications.1

1

Like Par's responses to interrogatories 9, 11, 13, and 15-18, Par's response to interrogatory 10 equivocally names two persons who "may have knowledge or information concerning the inquired-about topics." But unlike the other responses, Par's response to interrogatory 10 also includes a brief, one-paragraph description, in the most basic terms, of the timeline of Par's ANDA filing and paragraph IV notices. See Ex. B at 25.

Case 1:06-cv-00774-JJF

Document 217

Filed 04/04/2008

Page 7 of 12 4.

Interrogatory Nos. 9, 15, 16, and 17 seek information about product development and testing performed by or on behalf of Par. Interrogatory No. 9 asks Par to describe in detail the development of the products in ANDA 78-540, including any related documents or things. Par's entire response to this interrogatory is as follows: Subject to and without waiving any objections, Par identifies the following persons who may have knowledge or information concerning the inquired-about topics: Subject Matter Role in Development of ANDA 78-540 Eric Mittleberg, Ph.D. The research development and Executive Vice President formulation of the propafenone Pharmaceutical Research and HCl SR capsules that are the Development subject of Par's ANDA No. 78Par Pharmaceutical, Inc. 540 300 Tice Boulevard Woodcliff Lake, NJ 07677 Ping He - former Par employee The research development and formulation of the propafenone SR HCl capsules that are the subject of Par's ANDA No. 78540 Individual

1.

2.

Ex. B at 24. No information is provided regarding development efforts. Nor are any other personnel or any documents specifically identified. Par avoids the question entirely by

generically and tentatively nominating Messrs. Mittleberg and He as persons who may have knowledge of the topic. Interrogatory No. 15 asks Par to describe all testing of the products for which Par seeks FDA approval in ANDA 78-540, including results and conclusions, and to identify all personnel involved in such testing. Although the interrogatory asks for testing records,

descriptions of tests run, test results, and a complete list of testing personnel and the bases for

Case 1:06-cv-00774-JJF

Document 217

Filed 04/04/2008

Page 8 of 12 5.

their knowledge of Par's testing efforts, Par's response to this Interrogatory is identical to its response to Interrogatory No. 9. It names Messrs. Mittleberg and He as persons who may have knowledge but says no more. This response hardly scratches the surface of the information sought by the interrogatory. It makes no mention of testing efforts, results, or conclusions, and identifies no personnel other than Messrs. Mittleberg and He. Interrogatory No. 16 seeks information about testing Par performed with respect to any prior art patents or references, including the Pich `287 Patent, on which Par's invalidity and unenforceability assertions rely. Thus, Interrogatory No. 16 seeks information that goes directly to the heart of Par's defenses to infringement. There is no need to reprint Par's response to this interrogatory here because it is identical to its response to Interrogatory Nos. 9 and 15. Par equivocally names Messrs. Mittleberg and He as persons who may have relevant information, but does not describe any testing efforts, results, or other personnel involved, as the interrogatory requires. Interrogatory No. 17 seeks information about Par's development and testing efforts with respect to sustained-release propafenone products generally. This information could bear directly on infringement (through Par's alleged design-around efforts), and Par's defense of invalidity (through secondary considerations of obviousness). Again, there is no need to reprint Par's response: it is the same as its response to Interrogatory Nos. 9, 15, and 16. Par employs the same tactic in its responses to Interrogatory Nos. 10, 11, and 18. Interrogatory Nos. 10 and 11 inquire about ANDA 78-540. Specifically, they ask for details about the preparation and submission of the ANDA, and Par's motivation for and circumstances leading to the filing of the ANDA and the accompanying paragraph IV certification. Instead of answering these Interrogatories, Par provides a chart like the one reprinted above for

Case 1:06-cv-00774-JJF

Document 217

Filed 04/04/2008

Page 9 of 12 6.

Interrogatory Nos. 9, 15, 16, and 17. But for Interrogatory Nos. 10 and 11, the chart names Michelle Bonomi and Janis Picurro as the persons who may have knowledge about "[t]he preparation, filing and approval process for Par's ANDA 78-540." Ex. B at 25, 26. In

retrospect, Par's nomination of Ms. Bonomi and Ms. Picurro appears to have been mistaken, as the depositions of Ms. Bonomi and Ms. Picurro revealed that neither had even read ANDA 78540, let alone had any substantive role in its preparation or filing.2 Although Par's response to Interrogatory No. 10 included a one-paragraph summary of the dates on which its ANDA filings and paragraph IV certifications took place, Par offered no other information about the preparation of the filings, the motivation for the filings, or the circumstances under which the filings were made. Interrogatory No. 18 asks for information about Par's manufacturing processes for its proposed generic drug. Specifically, Interrogatory No. 18 requests information on the process for manufacturing Par's propafenone beadlets, including the "reactants, reactions, products, and by-products at each step of the manufacturing process." Ex. A at 9. This information is at the heart of this case. It bears directly on Reliant's claims of infringement and on Par's defense of non-infringement. Par's only response is the same chart it included in Interrogatory Nos. 9-11 and 15-17, but this chart lists Robert Polke and Karen Close as the persons who may have knowledge. Ex. B at 34. Par provides absolutely no response to Interrogatory No. 13, which seeks information about Par's marketing and sales projections for its proposed generic drug and for the market for sustained-release propafenone generally. This information relates to Par's motivation

2

Par's nomination of Ms. Bonomi and Ms. Picurro is the subject matter of a separate motion being filed today.

Case 1:06-cv-00774-JJF

Document 217

Filed 04/04/2008

Page 10 of 12 7.

for infringement and its defenses of invalidity (through secondary considerations of obviousness). Instead of responding, Par merely objects that "substantial documentary and/or testimonial discovery needs to be completed before Par may meaningfully respond to this interrogatory." Ex. B at 27. Fact discovery is about to end and Par has yet to supplement this response (or any of the responses discussed in this motion). Further evading substantive responses, each of Par's objections to Interrogatory Nos. 9, 11, 13, and 15-18 complains that "the discovery sought is unreasonably cumulative or duplicative, or is obtainable from a source that is more convenient, less burdensome, or less expensive than an interrogatory answer, e.g., from Par's documents, including its ANDA and documents produced in response to Reliant's Documents Request [document request number(s)]."3 See Ex. B passim. But even assuming Par had produced relevant documents, that does not relieve Par of its obligation to provide answers to Reliant's interrogatories. Fact discovery is coming to a close in this action. Both parties have produced documents and taken numerous depositions. Par has no credible excuse to avoid supplementing its interrogatory responses to provide substantive responses that identify specific pages and persons who do have knowledge. Accordingly, Reliant requests that the Court order Par to supplement its responses to interrogatories 9-11, 13, and 15-18 as required by Rule 33. C. Par Should Be Ordered to Supplement Its Responses to Interrogatories 7 and 12

Interrogatories 7 and 12 seek information about opinions of counsel regarding the `588 Patent generally, and specifically, with respect to ANDA 78-540 and Par's paragraph IV

3

Par's response to interrogatory 10 does not make such an objection.

Case 1:06-cv-00774-JJF

Document 217

Filed 04/04/2008

Page 11 of 12 8.

certification. Par responded to both interrogatories by objecting on the grounds of privilege and "stat[ing] that any opinions of counsel will be identified in a privilege log in compliance with the requirements of the Federal Rules of Civil Procedure and the Local Civil Rules of the District Court for the District of Delaware." Ex. B at 22, 27. Despite these assurances and despite explicit notice of the deficiency, Par has not provided any indication where opinions of counsel might be found in its four-hundred-forty-item privilege log; nor has Par affirmed that no such opinions of counsel exist. The bulk of Par's privilege log is filled with rote, vague descriptions substantially similar to "Confidential communication and confidential attachment containing and/or referring to legal advice regarding noninfringement of U.S. Patent No. 5,681,588." See, e.g., Ex. D at entries 2, 21, 45, 155, 204, 390, 410. Accordingly, Reliant requests that the Court order Par to supplement its responses to Interrogatory Nos. 7 and 12 to either (a) identify the entries in Par's privilege logs that relate to opinions of counsel or (b) affirm that no such opinions of counsel exist. CONCLUSION For the foregoing reasons, Reliant requests that the Court grant Reliant's Motion To Compel Par Pharmaceutical, Inc. to Supplement Its Interrogatory Responses. MORRIS, NICHOLS, ARSHT & TUNNELL LLP OF COUNSEL: John Desmarais Gerald J. Flattmann, Jr. Christine Willgoos KIRKLAND & ELLIS, LLP Citigroup Center 153 E. 53rd Street New York, NY 10022 (212) 446-4800 April 4, 2008
2283674

/s/ Jack B. Blumenfeld
Jack B. Blumenfeld (#1014) Maryellen Noreika (#3208) 1201 North Market Street P.O. Box 1347 Wilmington, DE 19899-1347 (302) 658-9200 [email protected] [email protected] Attorneys for Plaintiff

Case 1:06-cv-00774-JJF

Document 217

Filed 04/04/2008

Page 12 of 12

CERTIFICATE OF SERVICE I hereby certify that on April 4, 2008 I electronically filed the foregoing with the Clerk of the Court using CM/ECF, which will send notification of such filing to: Josy W. Ingersoll, Esquire YOUNG, CONAWAY, STARGATT & TAYLOR I further certify that I caused to be served copies of the foregoing document on April 4, 2008 upon the following in the manner indicated: Josy W. Ingersoll, Esquire YOUNG, CONAWAY, STARGATT & TAYLOR The Brandywine Building 1000 West Street, 17th Floor Wilmington, DE 19801 John G. Taylor, Esquire James K. Stronski, Esquire FROMMER LAWRENCE & HAUG LLP 745 Fifth Avenue New York, NY 10151 VIA ELECTRONIC MAIL and HAND DELIVERY

VIA ELECTRONIC MAIL

/s/ Jack B. Blumenfeld
Jack B. Blumenfeld (#1014)

Case 1:06-cv-00774-JJF

Document 217-2

Filed 04/04/2008

Page 1 of 90

Exhibit A

Case 1:06-cv-00774-JJF

Document 217-2

Filed 04/04/2008

Page 2 of 90

Case 1:06-cv-00774-JJF

Document 217-2

Filed 04/04/2008

Page 3 of 90

Case 1:06-cv-00774-JJF

Document 217-2

Filed 04/04/2008

Page 4 of 90

Case 1:06-cv-00774-JJF

Document 217-2

Filed 04/04/2008

Page 5 of 90

Case 1:06-cv-00774-JJF

Document 217-2

Filed 04/04/2008

Page 6 of 90

Case 1:06-cv-00774-JJF

Document 217-2

Filed 04/04/2008

Page 7 of 90

Case 1:06-cv-00774-JJF

Document 217-2

Filed 04/04/2008

Page 8 of 90

Case 1:06-cv-00774-JJF

Document 217-2

Filed 04/04/2008

Page 9 of 90

Case 1:06-cv-00774-JJF

Document 217-2

Filed 04/04/2008

Page 10 of 90

Case 1:06-cv-00774-JJF

Document 217-2

Filed 04/04/2008

Page 11 of 90

Case 1:06-cv-00774-JJF

Document 217-2

Filed 04/04/2008

Page 12 of 90

Exhibit B

Case 1:06-cv-00774-JJF

Document 217-2

Filed 04/04/2008

Page 13 of 90

CONFIDENTIAL EXHIBIT

Case 1:06-cv-00774-JJF

Document 217-2

Filed 04/04/2008

Page 14 of 90

Exhibit C

Case 1:06-cv-00774-JJF

Document 217-2

Filed 04/04/2008

Page 15 of 90

Case 1:06-cv-00774-JJF

Document 217-2

Filed 04/04/2008

Page 16 of 90

Exhibit D

Case 1:06-cv-00774-JJF

Document 217-2

Filed 04/04/2008

Page 17 of 90

PAR'S PRIVILEGED DOCUMENT LOG Reliant Pharmaceuticals, Inc. v. Par Pharmaceutical, Inc. Case No. 06-774 (JJF)@.Del.)

DOC NO.

DOCUMENT TYPE

DATE

AUTHOR(S)

ADDRESSEE(S)

COPY RECIPIENT(S)

GENERAL SUBJECT MATTER

PRlVlLEGE CLAIM

1.

E-mail string and memorandum

10/20/04

Robert Campanelli; Nicole Pace

2.

E-mail and memoranda E-mail and memorandum E-mail and memorandum

1019105

Robert Campanelli

Shu Zhu; Joseph Todisco; Robert Whalen; Farhan Aslam; Robert Calafati; Tina DeAngelo; Robert Campanelli; Angela Feniger, Nicole Pace Nandini Konar; Matthew Zrebiec

Robert Femia; Paul Campanelli

Confidential communications and confidential attachment between and among Par employees containing, legal advice regarding Par's noninfiingement position with respect to U.S. Patent No. 5,681,588 and Par's paragraph IV certification.

AC

Farhan Aslam; Chad Gassert

3.

11/8/04

Nicole Pace

Robert Campanelli; Farhan Aslam; Tina G. DeAngelo Shankar Hariharan; Robert Femia; Mike Graves; Robert Whalen; Shu Zhu; Donna Carluccio; Robert Calafati; Tina DeAngelo; Joseph Todisco; Robert Campanelli; Farhan Aslam; [email protected]; [email protected]; Brian Landmann; Michelle Bonomi; Janis Picurro Shankar Hariharan; Robert Femia; Mike Graves; Robert Whalen; Shu Zhu;

Paul Campanelli; Shu Zhu

4.

11/12/04

Nicole Pace

Paul Campanelli; Angela Feniger; Arthur Hoag; Angus Chen

Confidential communication and confidential attachments containing legal advice regarding noninfiingement of U.S Patent No. 5,681,588 and Par's formulation for propafenone. Confidential communication and confidential attachment containing legal advice regarding noninfiingement of U.S. Patent No. 5,681,588 and paragraph IV filing dates for Par's propafenone. Confidential communication and confidential attachment containing legal advice regarding noninfiingement of U.S. Patent No. 5,681,588 and paragraph IV filing dates for Par's propafenone.

AC

AC

AC

5.

E-mail and memorandum

11117/04

Nicole Pace

Paul Campanelli; Angela Feniger; Arthur Hoag; Angus Chen

Confidential communication and confidential attachment containing legal advice regarding noninfiingement of U.S. Patent No. 5,681,588 and paragraph IV filing dates for Par's propafenone.

AC

Case 1:06-cv-00774-JJF

Document 217-2

Filed 04/04/2008

Page 18 of 90

DOC NO.

DOCUMENT TYPE

DATE

AUTHOR(S)

ADDRESSEE(S)

COPY RECIPIENT(S)

GENERAL SUBJECT MATTER

PRIVILEGE CLAIM

6.

E-mail string and memorandum

11117/04

Robert Campanelli; Nicole Pace

7.

E-mail and memorandum

12/6/04

Nicole Pace

Donna Carluccio; Robert Calafati; Tina DeAngelo; Joseph Todisco; Robert Campanelli; Farhan Aslam; [email protected]; [email protected]; Brian Landmann; Michelle Bonomi; Janis Picurro; Kevin Campbell; Suketu Sanghvi Farhan Aslam; Shankar Hariharan; Robert Femia; Mike Graves; Robert Whalen; Shu Zhu; Donna Carluccio; Robert Calafati; Tina DeAngelo; Joseph Todisco; Robert Campanelli; Farhan Aslam; [email protected]; [email protected]; Brian Landmann; Michelle Bonomi; Janis Picurro; Kevin Campbell; Suketu Sanghvi Shankar Hariharan; Robert Femia; Mike Graves; Robert Whalen; Shu Zhu; Donna Carluccio; Robert Calafati; Tina DeAngelo; Joseph Todisco; Robert Campanelli; Farhan Aslam;

Paul Campanelli; Angela Feniger; Arthur Hoag; Angus Chen

Confidential communications and confidential attachment between and among Par attorneys and Par employees containing legal advice regarding noninfiingement of U.S. Patent No. 5,681,588 and paragraph IV filing dates for Par's propafenone.

AC

Paul Campanelli; Angela Feniger; Arthur Hoag; Angus Chen

Confidential communication and confidential attachment containing legal advice regarding noninfiingement of U.S. Patent No. 5,681,588 and paragraph IV filing dates for Par's propafenone.

AC

Case 1:06-cv-00774-JJF

Document 217-2

Filed 04/04/2008

Page 19 of 90

DOC NO.

DOCUMENT TYPE

DATE

AUTHOR(S)

ADDRESSEE(S)

COPY RECIPIENT(S)

GENERAL SUBJECT MATTER

PRIVILEGE CLAIM

8.

Memorandum

6117/05

Robert Campanelli

9.

E-mail and memorandum

12115/04

Robert Campanelli

[email protected]; [email protected]; Brian Landmann; Michelle Bonomi; Janis Picurro; Kevin Campbell; Suketu Sanghvi Farhan Aslam; Tina G . DeAngelo; Shankar Hariharan; Robert Femia; Michelle Bonomi; Joseph Barbarite; Ramu Surapanaene;N. Ragynathan; Suketu Sanghvi; Louis Donato; Karen Close; Paul DeJong; Thomas Bonitz; Janis Picurro Farhan Aslam

Confidential memorandum reflecting legal advice regarding noninfringement of U.S. Patent No. 5,681,588 and Par's formulation for propafenone.

AC

10.

E-mail string and memorandum E-mail and memorandum E-mail string and memorandum

12116/04

Robert Campanelli; Suketu Sanghvi

Farhan Aslam; Tina G. DeAngelo; Suketu Sanghvi; Shankar Hariharan Robert Campanelli

Robert Femia; Shankar Hariharan; Angela Feniger; Robert Campanelli

11.

12115/04

Farhan Aslam

12.

12/16/04

Robert Campanelli

Farhan Aslam; Tina G . DeAngelo; Shankar Hariharan; Robert Femia; Michelle Bonomi; Joseph Barbarite; Ramu Surapanaene; N. Ragynathan; Suketu Sanghvi; Louis

Confidential communication and confidential attachment containing legal advice regarding noninfringement of U.S. Patent No. 5,681,588 and Par's formulation for propafenone. Confidential communications and confidential attachment between and among Par employees reflecting legal advice regarding Par's noninfringement and invalidity positions as well as Par's paragraph IV certification. Confidential communication and confidential attachment containing, and/or referring to legal advice regarding noninfringement of U.S. Patent No. 5,681,588 and Par's formulation for propafenone. Confidential communications and confidential attachment between and among Par employees reflecting and referring to legal advice regarding noninfiingement of U.S. Patent No. 5,681,588 and Par's formulation for propafenone.

AC

AC

AC

AC

Case 1:06-cv-00774-JJF

Document 217-2

Filed 04/04/2008

Page 20 of 90

DOC NO.

DOCUMENT TYPE

DATE

AUTHOR(S)

ADDRESSEE(S)

COPY RECIPIENT(S)

GENERAL SUBJECT MATTER

PRIVILEGE CLAIM

13.

E-mail string and memorandum

12116/04

Robert Campanelli

14.

E-mail and memorandum

12/22/04

Nicole Pace

15.

E-mail string and memorandum

6130105

Farhan Aslam; Robert Campanelli

Donato; Karen Close; Paul DeJong; Thomas Bonitz; Janis Picurro Shankar Hariharan; Robert Fernia; Michelle Bonomi; Joseph Barbarite; Ramu Surapanaene; N. Ragynathan; Suketu Sanghvi; Louis Donato; Karen Close; Paul DeJong; Thomas Bonitz; Janis Picurro Shankar Hariharan; Robert Femia; Mike Graves; Robert Whalen; Shu Zhu; Donna Carluccio; Robert Calafati; Tina DeAngelo; Joseph Todisco; Robert Campanelli; Farhan Aslam; [email protected]; [email protected]; Brian Landaman; Michelle Bonomi; Janis Picurro; Kevin Campbell; Suketu Sanghvi Mary Connell; Achyut Bhatt; Bill Giglio; Damodar Patel; Greg Fariss; Janis Picurro; Jennifer Altneu; John Schultz; Joseph Todisco; Karen Close; Louis Donato; Luciane Haner; Michael Ryff; Michele LeTourneau; N Ragunathan;

Farhan Aslam

Confidential communications and confidential attachment between and among Par employees containing, reflecting andlor refemng to legal advice regarding Par's paragraph IV certification for propafenone.

AC

Paul Campanelli; Angela Feniger; Arthur Hoag; Angus Chen

Confidential communication and confidential attachment containing, referring to and requesting legal advice regarding noninfringement of U.S. Patent No. 5,68 1,588 and Par's propafenone formulation.

AC

Robert Campanelli; Robert Femia; Shankar Hariharan; Paul Campanelli; Scott Tarriff; Michelle Bonomi; Joseph Barbarite; Mike Graves; NickDiMaio; Stephen Montalto;

Confidential communications and confidential attachment between and among Par attorneys and Par employees containing, referring to and requesting legal advice regarding noninfringement of U.S. Patent No. 5,681,588 and Par's propafenone formulation.

AC

Case 1:06-cv-00774-JJF

Document 217-2

Filed 04/04/2008

Page 21 of 90

Case 1:06-cv-00774-JJF

Document 217-2

Filed 04/04/2008

Page 22 of 90

Case 1:06-cv-00774-JJF

Document 217-2

Filed 04/04/2008

Page 23 of 90

DOC NO.

DOCUMENT TYPE

DATE

AUTHOR(S)

ADDRESSEE(S)

COPY RECIPIENT(S)

GENERAL SUBJECT MATTER

PRIVILEGE CLAIM

18.

E-mail string and memorandum

1124105

Robert Campanelli

19.

E-mail and memorandum

2110105

Nicole Pace

Angus Chen; Veerappan Subramanian; Muthusamy Shanrnugam Paul Campanelli; Angela Feniger; Farhan Aslam; Tina G . Angela Feniger; Arthur Hoag DeAngelo; Shankar Hariharan; Robert Fernia; Mike Graves; Robert Whalen; Shu Zhu; Donna Carluccio; Robert Calafati; Tina DeAngelo; Joseph Todisco; Robert Campanelli; Farhan Aslam; Brian Landmann; Michelle Bonomi; Janis Picurro; Kevin Campbell; Suketu Sanghvi; Angus Chen; Veerappan Subramanian; Muthusamy Shanmugam Shankar Hariharan; Paul Campanelli; Angela Feniger; Robert Femia; Mike Arthur Hoag Graves; Robert Whalen; Shu Zhu; Donna Carluccio; Robert Calafati; Tina DeAngelo; Joseph Todisco; Robert Campanelli: Farhan Aslman; Brian Landmann; Michelle Bonomi; Janis Picurro; Kevin Campbell; Suketu Sanghvi; Angus Chen;

Confidential communications and confidential attachment between and among Par attorneys and Par employees containing, referring to and requesting legal advice regarding noninfringement of U.S. Patent No. 5,681,588 and Par's propafenone formulation.

AC

Confidential communication and confidential attachment containing, referring to and requesting legal advice regarding noninfringement of U.S. Patent No. 5,68 1,588 and Par's propafenone formulation.

AC

Case 1:06-cv-00774-JJF

Document 217-2

Filed 04/04/2008

Page 24 of 90

DOC NO.

DOCUMENT TYPE

DATE

AUTHOR(S)

ADDRESSEE(S)

COPY RECIPIENT(S)

GENERAL SUBJECT MATTER

PRIVILEGE CLAIM

20.

E-mail string and memorandum

211 5/05

Robert Campanelli

21.

E-mail and memorandum

3110105

Nicole Pace

22.

E-mailand memorandum E-mail and memorandum E-mail sting and memorandum E-mail string

1/3/06

Robert Campanelli

23.

311 7/05

Robert Campanelli

Veerappan Subramanian; Muthusammy Shanmugam Angela Feniger; Farhan Aslam; Tina G. DeAngelo; Scott Tarriff; Shankar Hariharan Shankar Hariharan; Robert Femia; Mike Graves; Robert Whalen; Shu Zhu; Donna Carluccio; Robert Calafati; Tina DeAngelo; Joseph Todisco; Robert Campanelli: Farhan Aslman; Brian Landmann; Michelle Bonomi; Janis Picurro; Kevin Campbell; Suketu Sanghvi; Angus Chen; Veerappan Subramanian; Muthusammy Shanmugam Nandini Konar; Farhan Aslam; Chad Gassert; Matthew Zrebiec Farhan Aslam

Carol Malagoli; Melissa Mokanos

Confidential communications and confidential attachment between and among Par employees reflecting, containing, and/or referring to legal advice regarding Par's propafenone formulation. Confidential communication and confidential attachment containing, referring to and requesting legal advice regarding noninfiingement of U.S. Patent No. 5,681,588 and Par's propafenone formulation.

AC

Paul Campanelli; Angela Feniger; Arthur Hoag

AC

Confidential communication and confidential attachment containing, reflecting and/or referring to legal advice regarding U.S. Patent No. 5,681,588. Confidential communication and confidential attachment between Par employees containing, reflecting, andlor referring to legal advice regarding Par's propafenone formulation. Confidential communications and confidential attachment between and among Par employees containing, reflecting and/or referring to legal advice regarding Par's propafenone formulation. Confidential communications and confidential

AC

AC

24.

9120105

Robert Campanelli; Mark Roach

25.

9/28/05

Robert Campanelli;

Farhan Aslam; Chad Gassert; Robert Campanelli; Shankar Hariharan Farhan Aslam; Chad

Ping He; Oscar Liu; Robert Femia

AC

Paul Campanelli;

AC

Case 1:06-cv-00774-JJF

Document 217-2

Filed 04/04/2008

Page 25 of 90

DOC NO.

DOCUMENT TYPE

DATE

AUTHOR(S)

ADDRESSEE(S)

COPY RECIPIENT(S)

GENERAL SUBJECT MATTER

PRIVILEGE CLAIM

and memorandum

Nicole Pace

26.

E-mail and memorandum E-mail and memorandum

3/28/05

Robert Campanelli

Gassert; Robert Campanelli; Shankar Hariharan; Robert Femia; Paul Campanelli; Shu Zhu; Angus Chen; Veerappan Subramanian; Muthusamy Shanrnugam; Donna Carluccio; Mike Graves; Kevin Campbell; Robert Calafati; Joseph Todisco; Robert Whalen; Brian Landmann; Suketu Sanghvi; Michelle Bonomi Farhan Aslam; Tina G. DeAngelo Angela Feniger; Farhan Aslam; Tina G. DeAngelo; Robert Campanelli; Tina DeAngelo; Farhan Aslman; Angela Feniger Robert Campanelli; Rachel Arcilla-Cigiao; Tina DeAngelo; Farhan Aslam; Angela Feniger Robert Campanelli; Farhan Aslam

Angela Feniger

attachment between and among Par attorneys and Par employees requesting, providing, containing, andor referring to legal advice regarding Par's development and launch dates for propafenone.

27.

3/30/05

Robert Campanelli

28.

E-mail string and memorandum

3/30/05

Farhan Aslam; Robert Campanelli

29.

E-mail string and memorandum

4/6/05

Farhan Aslam; Robert Campanelli

Rachel ArcillaCagiao; Tina DeAngelo;

30.

E-mail string and memoranda

4/6/05

Rachel Arcilla-Cagiao; Farhan Aslam

Angela Feniger; Tina DeAngelo; Rachel ArcillaCagiao;

Confidential communication and confidential attachment containing, reflecting andor referring to legal advice regarding patent exclusivity data for U.S. Patent No. 5,681,588. Confidential communication and confidential attachment containing, reflecting andor referring to legal advice regarding patent exclusivity data for U.S. Patent No. 5,681,588. Confidential communications and confidential attachment between and among Par employees containing, reflecting andor referring to legal advice regarding noninfiingement of U.S. Patent No. 5,681,588. Confidential communications and confidential attachment between and among Par employees containing, reflecting andor referring to legal advice regarding noninfiingement of U.S. Patent No. 5,68 1,588 and Par's formulation for propafenone. Confidential communications and confidential attachments between and among Par employees containing, reflecting andor referring to legal advice regarding noninfringement of U.S. Patent No.

AC

AC

AC

AC

AC

Case 1:06-cv-00774-JJF

Document 217-2

Filed 04/04/2008

Page 26 of 90

DOC NO.

DOCUMENT TYPE

DATE

AUTHOR(S)

ADDRESSEE(S)

COPY RECIPIENT(S)

GENERAL SUBJECT MATTER

PRIVILEGE CLAIM

3 1.

E-mail and memorandum

4112/05

Farhan Aslam

Nicole Pace

32.

E-mail and memorandum

411 3/05

Farhan Aslam

Rachel Arcilla-Cagiao

Robert Campanelli

33.

E-mail string and memorandum

4113/05

Nicole Pace; Farhan Aslam

Farhan Aslam; Nicole Pace

34.

E-mail string and memoranda E-mail and memoranda

4113/05

Rachel Arcilla-Cagiao; Rachel Arcilla-Cagiao; Robert Campanelli Farhan Aslam Farhan Aslam

35.

4120105

Tina G. DeAngelo

Rachel Arcilla-Cagiao

Robert Campanelli; Farhan Aslam; George Chen; Angela Feniger

5,681,588 and Par's formulation for propafenone. Confidential communication and confidential attachment containing, reflecting andor refemng to legal advice regarding noninfiingement of U.S. Patent No. 5,681,588 and Par's formulation for propafenone. Confidential communication and confidential attachment containing, reflecting andor referring to legal advice regarding noninfiingement of U.S. Patent No. 5,68 1,588 and Par's formulation for propafenone. Confidential communications and confidential attachment between and among Par employees containing, reflecting andlor referring to legal advice regarding noninfiingement of U.S. Patent No. 5,681,588. Confidential communications and confidential attachments between and among Par employees containing, reflecting andor refemng to legal advice regarding noninfiingernent of U.S. Patent No. 5,68 1,588 and Par's formulation for propafenone. Confidential communication and confidential attachment containing, reflecting andor referring to legal advice regarding noninfiingement of U.S. Patent No. 5,681,588 and Par's formulation for propafenone. Confidential communication and confidential attachment containing andor referring to legal advice regarding noninfiingement of U.S. Patent No. 5,681,588.

AC

AC

AC

AC

AC

36.

E-mail and memorandum

9/8/05

Robert Campanelli

37.

E-mail and report

4/27/05

Robert Campanelli

Robert Femia; Paul Campanelli; N Ragunathan; Suketu Sanghvi; Mark Roach; Michelle Bonomi; Shankar Hariharan; Lynn Kramer; Joseph Barbarite; Ramu Surapanaene; Janis Picurro; Paul DeJong; Thomas Bonitz; Jodi Gutierrez Robert Femia; Paul Campanelli; N Ragunathan; Suketu Sanghvi; Mark Roach; Michelle Bonomi;

AC

Confidential communication and confidential attachment containing andor referring to legal advice regarding noninfringement of U.S. Patent No. 5,681,588 and patentability of Par's propafenone formulation.

AC

Case 1:06-cv-00774-JJF

Document 217-2

Filed 04/04/2008

Page 27 of 90

DOC NO.

DOCUMENT TYPE

DATE

AUTHOR(S)

ADDRESSEE(S)

COPY RECIPIENT(S)

GENERAL SUBJECT MATTER

PRIVILEGE CLAIM

38.

E-mail string and report

12/1/05

Robert Campanelli; Robert Campanelli

39.

E-mail and report

2/24/05

Robert Campanelli

40.

E-mail and report

6/22/05

Robert Campanelli

41.

E-mail and report

511 1/05

Robert Campanelli

Shankar Hariharan; Lynn Kramer; Joseph Barbarite; Ramu Surapanaene; Janis Picuno; Paul DeJong; Thomas Bonitz; Jodi Gutierrez Robert Femia; Suketu Sanghvi; Donald Cilla; Lynn Kramer; Joseph Barbarite; Shankar Hariharan; Scott Tarriff Robert Femia; N Ragunathan; Suketu Sanghvi; Mark Roach; Michelle Bonomi; Shankar Hariharan; Joseph Barbarite; Ramu Surapanaene; Janis Picurro; Paul DeJong; Thomas Bonitz Robert Femia; N Ragunathan; Suketu Sanghvi; Mark Roach; Michelle Bonomi; Donald Cilla; Shankar Hariharan; Lynn Kramer; Joseph Barbarite; Ramu Surapanaene; Paul DeJong; Jodi Gutierrez Robert Femia; N Ragunathan; Suketu Sanghvi; Mark Roach; Michelle Bonomi; Shankar Hariharan; Lynn Kramer; Joseph Barbarite; Ramu

Elizabeth Bukowiec; Carol Malagoli

Confidential communication and confidential attachment containing and/or referring to legal advice regarding noninfringement of U.S. Patent No. 5,68 1,588 and patentability of Par's propafenone formulation. Confidential communication and confidential attachment containing and/or referring to legal advice regarding noninfringement of U.S. Patent No. 5,681,588 and patentability of Par's propafenone formulation.

AC

AC

Confidential communication and confidential attachment containing and/or referring to legal advice regarding noninfringement of U.S. Patent No. 5,681,588 and patentability of Par's propafenone formulation.

AC

Confidential communication and confidential attachment containing and/or referring to legal advice regarding noninfiingement of U.S. Patent No. 5,68 1,588 and patentability of Par's propafenone formulation.

AC

Case 1:06-cv-00774-JJF

Document 217-2

Filed 04/04/2008

Page 28 of 90

DOC NO.

DOCUMENT TYPE

DATE

AUTHOR(S)

ADDRESSEE(S)

COPY RECIPIENT(S)

GENERAL SUBJECT MATTER

PRIVILEGE CLAIM

42.

E-mail and report

6116/05

Robert Campanelli

43.

E-mail and report

5/25/05

Robert Campanelli

44.

E-mail and reports

1118/05

Angela Feniger

Surapanaene; Paul DeJong Robert Femia; N Ragunathan; Suketu Sanghvi; Mark Roach; Michelle Bonomi; Donald Cilla; Shankar Hariharan; Lynn Kramer; Joseph Barbarite; Ramu Surapanaene; Paul DeJong; Jodi Gutierrez Robert Femia; N Ragunathan; Suketu Sanghvi; Mark Roach; Michelle Bonomi; Shankar Hariharan; Lynn Kramer; Joseph Barbarite; Ramu Surapanaene; Paul DeJong Jackie Guerra; Achyut Bhatt; Bill Giglio; Damodar Melissa Mokanos; Patel; Greg Fariss; Melissa Zerrenner; Janis Picurro; Jennifer Yvette Irizarry; Pat Altneu; John Schultz; Cuccio; Denise Joseph Todisco; Karen Tavares Close; Louis Donato; Luciane Haner; Michael Ryff; Michele LeTourneau; Michelle Bonomi; Mike Graves; N Ragunathan; Natividad Ysla; Nick DiMaio; Oscar Fishkis; Pawel Kolano; Ping He; Ramu Surapanaene; Robert Calafati; Robert

Confidential communication and confidential attachment containing andor referring to legal advice regarding noninfringement of U.S. Patent No. 5,681,588 and patentability of Par's propafenone formulation.

AC

Confidential communication and confidential attachment containing andor referring to legal advice regarding noninfringement of U.S. Patent No. 5,681,588 and patentability of Par's propafenone formulation.

AC

Confidential communication and confidential attachment containing andlor referring to legal advice regarding noninfiingement of U.S. Patent No. 5,68 1,588 and patentability of Par's propafenone formulation.

AC

Case 1:06-cv-00774-JJF

Document 217-2

Filed 04/04/2008

Page 29 of 90

DOC NO.

DOCUMENT TYPE

DATE

AUTHOR(S)

ADDRESSEE(S)

COPY RECIPIENT(S)

GENERAL SUBJECT MATTER

PRIVILEGE CLAIM

45.

E-mail and report

3117/05

Robert Campanelli

46.

E-mail and report

6/9/05

Robert Campanelli

Campanelli; Robert Femia; Roger Keintz; Shu Zhu; Stephen Montalto; Thomas Rogan; Tina G. DeAngelo; Donna Carluccio; Nicole Pace; Paul Campanelli; Suketu Sanghvi; Shankar Hariharan; Lisa Braddock; Sunil R Patel; Janak Thaker; Joseph Barbarite; Carl Rucker; Robert Whalen; Adam Dunko; Lisa M Cosentino; Farhan Aslam; Prasad Narayana; Farhan Aslam; Laureen Shoemaker Robert Femia; N Ragunathan; Suketu Sanghvi; Melissa Mokanos; Mark Roach; Michelle Bonomi; Shankar Hariharan; Joseph Barbarite; Ramu Surapanaene; Janis Picurro; Paul DeJong; Thomas Bonitz; Jodi Gutierrez Robert Femia; N Ragunathan; Suketu Sanghvi; Mark Roach; Michelle Bonomi; Donald Cilla; DCilla; Shankar Hariharan; Lynn Kramer; Joseph

Confidential communication and confidential attachment containing andor referring to legal advice regarding noninfiingement of U.S. Patent No. 5,681,588 and patentability of Par's propafenone formulation.

AC

Confidential communication and confidential attachment containing andor referring to legal advice regarding noninfiingement of U.S. Patent No. 5,681,588 and patentability of Par's propafenone formulation.

AC

Case 1:06-cv-00774-JJF

Document 217-2

Filed 04/04/2008

Page 30 of 90

DOC NO.

DOCUMENT TYPE

DATE

AUTHOR(S)

ADDRESSEE(S)

COPY RECIPIENT(S)

GENERAL SUBJECT MATTER

PRIVILEGE CLAIM

47.

E-mail string and report

12115/04 12116/04

Shankar Hariharan; Robert Femia; Suketu Sanghvi

Barbarite; Ramu Surapanaene; Paul DeJong; Jodi Gutierrez Shankar Hariharan; Robert Femia; Suketu Sanghvi

Robert Campanelli; Robert Femia; Suketu Sanghvi; Joseph Barbarite; N Ragunathan; Shankar Hariharan

Confidential communications and confidential attachment between and among Par employees requesting, providing, containing, andor referring to legal advice regarding noninfiingement of U.S. Patent No. 5,681,588, prepared in anticipation of trial or litigation. Confidential communication and confidential attachment containing andor referring to legal advice regarding noninfringement of U.S. Patent No. 5,68 1,588.

ACJWP

48.

E-mail and report

6/2/05

Robert Campanelli

49.

E-mail and report

1/7/05

Robert Campanelli

50.

E-mail and report

1/20/05

Robert Campanelli

Robert Femia; N Ragunathan; Suketu Sanghvi; Mark Roach; Michelle Bonomi; Shankar Hariharan; Lynn Kramer; Joseph Barbarite; Ramu Surapanaene; Paul DeJong Shankar Hariharan; Robert Femia; Michelle Bonomi; Joseph Barbarite; Ramu Surapanaene; N Ragunathan; Suketu Sanghvi; Louis Donato; Karen Close; Paul DeJong; Thomas Bonitz; Janis Picurro Robert Femia; N Ragunathan; Suketu Sanghvi; Michelle Bonomi; Shankar Hariharan; Joseph Barbarite; Karen Close; Ramu Surapanaene; Janis Picurro; Louis Donato; Paul DeJong; Thomas

AC

Confidential communication and confidential attachment containing andor referring to legal advice regarding noninfiingement of U.S. Patent No. 5,68 1,588.

AC

Confidential communication and confidential attachment containing andor referring to legal advice regarding noninfringement of U.S. Patent No. 5,68 1,588.

AC

Case 1:06-cv-00774-JJF

Document 217-2

Filed 04/04/2008

Page 31 of 90

DOC NO.

DOCUMENT TYPE

DATE

AUTHOR(S)

ADDRESSEE(S)

COPY RECIPIENT(S)

GENERAL SUBJECT MATTER

PRIVILEGE CLAIM

5 1.

E-mail and reports

813 1105

Robert Campanelli

52.

E-mail and report

1/27/05

Robert Campanelli

53.

E-mail and report

1013 1/05

Robert Campanelli

54.

E-mail and report

9/29/05

Robert Campanelli

55.

E-mail and

1/13/05

Robert Campanelli

Bonitz Robert Femia; Suketu Carol Malagoli; Sanghvi; Mark Roach; Melissa Mokanos Donald Cilla; Lynn Kramer; Muthusamy Shanrnugam; Joseph Barbarite; Veerappan Subramanian; Michelle Bonomi; Shnkar Hariharan; Scott Tamff Robert Femia; N Ragunathan; Suketu Sanghvi; Michelle Bonomi; Shankar Hariharan; Joseph Barbarite; Karen Close; Ramu Surapanaene; Janis Picurro; Louis Donato; Paul DeJong; Thomas Bonitz Carol Malagoli; Robert Fernia; Suketu Sanghvi; Mark Roach; Rachel ArcillaMichelle Bonomi; Cagiao Donald Cilla; Lynn Kramer; Joseph Barbarite; Michelle Bonomi; Hariharan; Scott Tarriff Carol Malagoli; Robert Femia; Suketu Sanghvi; Mark Roach; Rachel ArcillaCagiao Michelle Bonomi; Donald Cilla; Lynn Kramer; Muthusamy Shanmugam; Joseph Barbarite; Veerappan Subramanian; Shankar Hariharan; Scott Tamff Robert Femia; N

Confidential communication and confidential attachment containing and/or referring to legal advice regarding noninfringement of U.S. Patent No. 5,681,588.

AC

Confidential communication and confidential attachment containing andor referring to legal advice regarding noninfringement of U.S. Patent No. 5,681,588.

AC

Confidential communication and confidential attachment containing andor refemng to legal advice regarding noninfiingement of U.S. Patent No. 5,681,588, prepared in anticipation of trial or litigation.

AC/WP

Confidential communication and confidential attachment containing andor referring to legal advice regarding noninfringement of U.S. Patent No. 5,681,588, prepared in anticipation of trial or litigation.

AC/WP

Confidential communication and confidential

AC

Case 1:06-cv-00774-JJF

Document 217-2

Filed 04/04/2008

Page 32 of 90

Case 1:06-cv-00774-JJF

Document 217-2

Filed 04/04/2008

Page 33 of 90

DOC NO.

DOCUMENT TYPE

DATE

AUTHOR(S)

ADDRESSEE(S)

COPY RECIPIENT(S)

GENERAL SUBJECT MATTER

PRIVILEGE CLAIM

report

60.

E-mail and report

1/13/05

Robert Campanelli

61.

E-mail and report

4/1/05

Robert Campanelli

Ragunathan; Suketu Sanghvi; Michelle Bonomi; Shankar Hariharan; Joseph Barbarite; Karen Close; Ramu Surapanaene; Janis Picurro; Louis Donato; Paul DeJong; Thomas Bonitz Robert Femia; N Ragunathan; Suketu Sanghvi; Michelle Bonomi; Shankar Hariharan; Joseph Barbarite; Karen Close; Ramu Surapanaene; Janis Picurro; Louis Donato; Paul DeJong; Thomas Bonitz Joseph Barbarite

attachment containing andor referring to legal advice regarding noninfiingement of U.S. Patent No. 5,681,588 and patentability of Par's propafenone formulation.

Confidential communication and confidential attachment containing andor referring to legal advice noninfiingement of U.S. Patent No. 5,681,588.

AC

62.

E-mail and report

12116/04

Robert Campanelli

63.

E-mail and report

1/27/05 1/31/05

Robert Campanelli

Shankar Hariharan; Robert Femia; Michelle Bonomi; Joseph Barbarite; Ramu Surapanaene; N Ragunathan; Suketu Sanghvi; Louis Donato; Karen Close; Paul DeJong; Thomas Bonitz; Janis Picurro Robert Femia; N Ragunathan; Suketu Sanghvi; Michelle Bonomi; Shankar Hariharan; Joseph

Confidential communication and confidential attachment containing and/or referring to legal advice regarding noninfiingement of U.S. Patent No. 5,681,588 and patentability of Par's propafenone formulation. Confidential communication and confidential attachment containing and/or referring to legal advice noninfiingement of U.S. Patent No. 5,681,588.

AC

AC

Confidential communication and confidential attachment containing andor referring to legal advice noninfiingement of U.S. Patent No. 5,681,588.

AC

Case 1:06-cv-00774-JJF

Document 217-2

Filed 04/04/2008

Page 34 of 90

DOC NO.

DOCUMENT TYPE

DATE

AUTHOR(S)

ADDRESSEE(S)

COPY RECIPIENT(S)

GENERAL SUBJECT MATTER

PRIVILEGE CLAIM

64.

E-mail and report

1/19/05

Robert Campanelli

65.

E-mail and report

713 1105 8/1/05

Robert Campanelli

66.

E-mail and memorandum

12/20/06

Katherine Burns

Barbarite; Karen Close; Ramu Surapanaene; Janis Picurro; Louis Donato; Paul DeJong; Thomas Bonitz Robert Femia; N Ragunathan; Suketu Sanghvi; Michelle Bonomi; Shankar Hariharan; Joseph Barbarite; Karen Close; Ramu Surapanaene; Janis Picurro; Louis Donato; Paul DeJong; Thomas Bonitz Robert Femia; Suketu Sanghvi; Mark Roach; Donald Cilla; Lynn Kramer; Muthusamy Shanmugam; Joseph Barbarite; Veerappan Subramanian; Jodi Gutierrez; Shankar Hariharan; Scott Tamff All Par Employees

Confidential communication and confidential attachment containing andor referring to legal advice noninfiingement of U.S. Patent No. 5,681,588.

AC

Carol Malagoli; Melissa Mokanos

Confidential communication and confidential attachment containing andor referring to legal advice noninfiingement of U.S. Patent No. 5,681,588.

AC

67.

E-mail string

3/14/06 3116/06

Michelle Bonomi; Eric Mittleberg; Paul Campanelli; Robert Campanelli

Janis Picurro; Suketu Sanghvi; Muthusamy Shanmugam; Alfred Elvin; Mark Roach; John Joseph; Michelle Bonomi; Kala Patel; Robert Campanelli;

Confidential communication and confidential attachment containing andor refemng to legal advice regarding document retention in the Reliant v. Par litigation, prepared in anticipation of trial or litigation. Confidential communications between and among Par Paul Campanelli; attorneys and Par employees requesting, providing, Robert Campanelli; Angus containing, andor refemng to legal advice filing of regarding noninfiingement of U.S. Patent No. Chen; Shankar Hariharan; 5,681,588 and regarding Par paragraph IV notice regarding propafenone, prepared in anticipation of Alfied T. Elvin; trial or litigation. Chad Gassert; Eric Mittleberg; Farhan Aslam; Matthew Zrebiec;

ACmP

ACNP

Case 1:06-cv-00774-JJF

Document 217-2

Filed 04/04/2008

Page 35 of 90

DOC NO.

DOCUMENT TYPE

DATE

AUTHOR(S)

ADDRESSEE(S)

COPY RECIPIENT(S)

GENERAL SUBJECT MATTER

PRIVILEGE CLAIM

68.

E-mail string

11/8/06

Michelle Bonomi; Angus Chen

Shankar Hariharan; Paul Campanelli; Eric Mittleberg; Angus Chen Steven Engel; Arthur Hoag; Michelle Bonomi

Nandini Konar

Andrew Wasson

69.

E-mail

11/8/06

Angus Chen

Michelle Bonomi; Arthur Hoag

Andrew Wasson

70.

E-mail string

11/8/06

Michelle Bonomi; Angus Chen

Karen Rocco; Julie Szozda; Arthur Hoag; Michelle Bonomi Blaine Hackman; Michelle Bonomi

Janis Picurro; Andrew Wasson

7 1.

E-mail string

11120106 11/27/06

Michelle Bonomi; Blaine Hackman

72.

E-mail string

11/20/06 11/21/06

Michelle Bonomi; Blaine Hackman

Julie Szozda; Michelle Bonomi

Janis Picurro

73.

E-mail and memorandum

7/24/06

Paul Campanelli

Nicole Pace

74.

E-mail and report E-mail and report

8/22/06

Nicole Pace

Paul Campanelli

75.

9/1/06

Nicole Pace

Paul Campanelli; Thomas Haughey

Angus Chen

Confidential communications between and among Par attorneys and Par employees requesting, providing, containing, andor referring to legal advice regarding Par paragraph IV notice regarding propafenone, prepared in anticipation of litigation or trial. Confidential communications requesting, providing, containing, andor referring to legal advice regarding Par paragraph IV notice regarding propafenone, prepared in anticipation of litigation or trial. Confidential communications between and among Par attorneys and Par employees requesting, providing, containing, andor referring to legal advice regarding Par paragraph IV notice regarding propafenone, prepared in anticipation of litigation or trial. Confidential communications between and among Par attorneys and Par employees requesting, providing, containing, andor referring to legal advice regarding Par paragraph IV notice regarding propafenone, prepared in anticipation of litigation or trial. Confidential communications between and among Par attorneys and Par employees requesting, providing, containing, andor referring to legal advice regarding Par paragraph IV notice regarding propafenone, prepared in anticipation of litigation or trial. Confidential communication and confidential attachment containing andor referring to legal advice regarding noninliingement of U.S. Patent No. 5,681,588, prepared in anticipation of trial or litigation. Confidential communication and confidential attachment containing andor referring to legal advice regarding anticipated propafenone litigation, prepared in anticipation of trial or litigation. Confidential communication and confidential attachment containing andor referring to legal advice regarding anticipated propafenone litigation, prepared in anticipation of trial or litigation.

ACIWP

ACIWP

ACIWP

ACIWP

ACIWP

ACIWP

ACNP

ACIWP

Case 1:06-cv-00774-JJF

Document 217-2

Filed 04/04/2008

Page 36 of 90

DOC NO.

DOCUMENT TYPE

DATE

AUTHOR(S)

ADDRESSEE(S)

COPY RECIPIENT(S)

GENERAL SUBJECT MATTER

PRIVILEGE CLAIM

76.

E-mail string and report

9/1/06 9/2/06

Paul Campanelli; Nicole Pace

77.

E-mail

10111/06

Robert Campanelli

Carol Vallillo; Paul Campanelli; Robert Campanelli; Joseph Todisco; Robert Whalen; Donna Carluccio; Shankar Hariharan; Angus Chen; Mike Graves; Kevin Campbell; Suketu Sanghvi; Arthur Hoag; Michelle Bonomi; Janis Picurro; Muthusamy Shanmugam; Blaine Hackman; Aleksandar Miletic; Eric Mittleberg; Maureen Cavanaugh Angus Chen

Confidential communication and confidential attachments requesting information for the purpose of rendering legal advice regarding noninfringement of U.S. Patent No. 5,68 1,588, including propafenone.

AC

78.

E-mail string

10111/06

Robert Campanelli; Angus Chen

79.

E-mail and report

11113/06

Robert Campanelli

Robert Fernia; Damodar Patel; Ping He; Suketu Sanghvi; Femia Arshad Kagalwalla

Robert Campanelli

80.

E-mail string and letter

8130106 9115106

Robert Campanelli; Robert Femia; Angus Chen

Eric Mittleberg; Suketu Sanghvi; Angus Chen; Ping He; Damodar Patel; Robert Fernia

Robert Campanelli; Damodar Patel; Ping He; Suketu Sanghvi

Confidential communication providing information for the purpose of obtaining legal advice regarding Par paragraph IV notice regarding propafenone, prepared in anticipation of litigation or trial. Confidential communications between and among Par attorneys and Par employees requesting, providing, containing, and/or referring to legal advice regarding the prosecution of U.S. Patent Application No. 111486,375 Confidential communication and confidential attachment containing and/or referring to legal advice regarding noninfr-ingement of U.S. Patent No. 5,68 1,588, prepared in anticipation of trial or litigation. Confidential communications and confidential attachment between and among Par attorneys and Par employees requesting, providing, containing, and/or referring to legal advice regarding declaration and power of attorney of U.S. Patent Application No. 111486,375.

AC/WP

AC/WP

AC/WP

AC

Case 1:06-cv-00774-JJF

Document 217-2

Filed 04/04/2008

Page 37 of 90

DOC
NO.

DOCUMENT TYPE

DATE

AUTHOR(S)

ADDRESSEE(S)

COPY RECIPIENT(S)

GENERAL SUBJECT MATTER

PRIVILEGE CLAIM

8 1.

E-mail string

8130106 9/22/06

Angus Chen; Robert Femia; Robert Campanelli Angus Chen; Robert Femia

Suketu Sanghvi; Angus Chen; Ping He; Damodar Patel Suketu Sanghvi; Angus Chen; Ping He; Damodar Patel; Robert Femia

Robert Campanelli

82.

E-mail string and letter

8130106 9/22/06

Robert Campanelli

83.

E-mail

11/20/06

Alan Kipnes

Angus Chen

84.

E-mail string

11/20/06

Angus Chen; Alan Kipnes Ping He

Blaine Hackman; Angus Chen Angus Chen

85.

E-mail

11/21/06

Oscar Liu; Suketu Sanghvi Blaine Hackman; Oscar Liu; Suketu Sanghvi

86.

E-mail string and memorandum E-mail string

11121/06

Angus Chen; Ping He

Allen R. Kipnes; Angus Chen

87.

6/29/06 7/12/06

Angus Chen; Courtenay Brinckerhoff; Ping He

Ping He; Suketu Sanghvi; Angus Chen; Courtenay Brinckerhoff Angus Chen; Ping He; Suketu Sanghvi; Angus Chen; Courtenay Brinckerhoff Angus Chen; Courtenay Brinckerhoff

Benjamin Berkowitz

88.

E-mail string

6/29/06 7112/06

Suketu Sanghvi; Angus Chen; Courtenay Brinckerhoff; Ping He Angus Chen; Courtenay Brinckerhoff; Ping He

Benjamin Berkowitz

89.

E-mail string

6/29/06 7112/06

Benjamin Berkowitz

Confidential communications between and among Par attorneys and Par employees requesting, providing, containing, andor referring to legal advice regarding declaration and power of attorney of U.S. Patent Application No. 111486,375. Confidential communications and confidential attachment between and among Par attorneys and Par employees requesting, providing, containing, andor referring to legal advice regarding declaration and power of attorney of U.S. Patent Application No. 111486,375. Confidential communication requesting information for the purpose of rendering legal advice regarding testing protocol for propafenone. Confidential communications between and among Par attorneys and Par employees requesting, providing, containing, andor referring to legal advice regarding testing protocol for propafenone. Confidential communication providing information for the purpose of obtaining legal advice regarding testing protocol for propafenone. Confidential communications and confidential attachment between and among Par attorneys and Par employees requesting, providing, containing, andor referring to legal advice regarding testing protocol for propafenone. Confidential communications between and among Par attorneys and Par employees requesting, providing, containing, andor referring to legal advice regarding the preparation of U.S. Patent Application No. 111486,375. Confidential communications between and among Par attorneys and Par employees requesting, providing, containing, andor referring to legal advice regarding the preparation of U.S. Patent Application No. 111486,375. Confidential communications between and among Par attorneys and Par employees requesting, providing, containing, andor referring to legal advice regarding the preparation of U.S. Patent Application No. 111486,375.

AC

AC

AC AC

AC

AC

AC

AC

AC

Case 1:06-cv-00774-JJF

Document 217-2

Filed 04/04/2008

Page 38 of 90

DOC NO.

DOCUMENT TYPE

DATE

AUTHOR(S)

ADDRESSEE(S)

COPY RECIPIENT(S)

GENERAL SUBJECT MATTER

PRIVILEGE CLAIM

90.

E-mail string

6/29/06 7/12/06

Angus Chen; Courtenay Brinckerhoff; Ping He

Angus Chen; Courtenay Brinckerhoff

Benjamin Berkowitz

9 1.

E-mail string

6/29/06 7112/06

Angus Chen; Courtenay Brinckerhoff; Ping He

Angus Chen; Courtenay Brinckerhoff

Benjamin Berkowitz

92.

E-mail string

6/29/06 7/12/06

Angus Chen; Courtenay Brinckerhoff; Ping He

Angus Chen; Courtenay Brinckerhoff

Benjamin Berkowitz

93.

E-mail string

6/29/06 7112/06

Angus Chen; Courtenay Brinckerhoff; Ping He Angus Chen; Courtenay Brinckerhoff; Ping He Angus Chen; Courtenay Brinckerhoff; Ping He

Angus Chen; Courtenay Brinckerhoff

Benjamin Berkowitz

94.

E-mail string

6/29/06 7/12/06

Angus Chen; Courtenay Brinckerhoff ~ngusChen; Courtenay Brinckerhoff

Benjamin Berkowitz

95.

E-mail string

6/29/06 7/12/06

Benjamin Berkowitz

96.

E-mail string

7112/06

Robert Femia; Angus Chen

Angus Chen; Robert Femia

97.

E-mail

7112/06

Angus Chen

Robert Femia

98.

E-mail string

6/29/06 7/12/06

Angus Chen; Courtenay

Ping He; Suketu Sanghvi; Angus Chen;

Benjamin Berkowitz

Confidential communications between and among Par AC attorneys and Par employees requesting, providing, containing, andor referring to legal advice regarding the preparation of U.S. Patent Application No. 111486,375. Confidential communications between and among Par AC attorneys and Par employees requesting, providing, containing, andor referring to legal advice regarding the preparation of U.S. Patent Application No. 111486,375. Confidential communications between and among Par AC attorneys and Par employees requesting, providing, containing, andor referring to legal advice regarding the preparation of U.S. Patent Application No. 111486,375. Confidential communications between and among Par AC attorneys and Par employees requesting, providing, containing, andor referring to legal advice regarding the preparation of U.S. Patent Application No. 111486,375. Confidential communications between and among Par AC attorneys and Par employees requesting, providing, containing, andor referring to legal advice regarding the preparation of U.S. Patent Application No. 111486,375. Confidential communications between and among Par AC attorneys and Par employees requesting, providing, containing, andor referring to legal advice regarding the preparation of U.S. Patent Application No. 111486,375. Confidential communications between and among Par AC attorneys and Par employees providing, containing, andor referring to legal advice regarding the preparation of U.S. Patent Application No. 111486,375. Confidential communication requesting information AC for the purpose of rendering legal advice regarding the preparation of U.S. Patent Application No. 111486,375. Confidential communications between and among Par AC attorneys and Par employees requesting, providing,

Case 1:06-cv-00774-JJF

Document 217-2

Filed 04/04/2008

Page 39 of 90

DOC NO.

DOCUMENT TYPE

DATE

AUTHOR(S)

ADDRESSEE(S)

COPY RECIPIENT(S)

GENERAL SUBJECT MATTER

PRIVILEGE CLAIM

Brinckerhoff; Ping He 6/29/06 7/12/06

99.

E-mail string

Angus Chen; Courtenay Brinckerhoff; Ping He; Damodar Pate1 Angus Chen; Courtenay Brinckerhoff; Ping He; Damodar Pate1 Angus Chen; Courtenay Brinckerhoff; Ping He Angus Chen; Courtenay Brinckerhoff; Ping He

100.

E-mail string

6/29/06 7/12/06

101.

E-mail string

6/29/06 7/13/06

102.

E-mail string

6/29/06 7113/06

Courtenay Brinckerhoff; Damodar Pate1 Ping He; Suketu Sanghvi; Angus Chen; Courtenay Brinckerhoff; Damodar Pate1 Ping He; Suketu Sanghvi; Angus Chen; Courtenay Brinckerhoff; Damodar Patel Ping He; Suketu Sanghvi; Angus Chen; Courtenay Brinckerhoff; Damodar Pate1 Angus Chen; Courtenay Brinckerhoff Ping He; Suketu Sanghvi; Angus Chen; Courtenay Brinckerhoff; Damodar Patel Ping He; Suketu Sanghvi; Angus Chen; Courtenay Brinckerhoff; Damodar Patel Angus Chen; Courtenay Brinckerhoff Angus Chen; Courtenay Brinckerhoff

Benjamin Berkowitz

Benjamin Berkowitz

Damodar Patel; Benjamin Berkowitz Benjamin Berkowitz

103.

E-mail string

6/29/06 7/13/06

Angus Chen; Courtenay Brinckerhoff; Ping He

Damodar Patel; Benjamin Berkowitz

104.

E-mail string

6/29/06 7/13/06

Angus Chen; Courtenay Brinckerhoff; Ping He Angus Chen; Courtenay Brinckerhoff; Ping He Angus Chen; Courtenay Brinckerhoff; Ping He

Damodar Patel; Benjamin Berkowitz Benjamin Berkowitz

105.

E-mail string

6/29/06 7/13/06

106.

E-mail string

6/29/06 7113/06

Benjamin Berkowitz

containing, andor referring to legal advice regarding the preparation of U.S. Patent Application No. 111486,375. Confidential communications between and among Par attorneys and Par employees requesting, providing, containing, andor referring to legal advice regarding the preparation of U.S. Patent Application No. 111486,375. Confidential communications between and among Par attorneys and Par employees requesting, providing, containing, andlor referring to legal advice regarding the preparation of U.S. Patent Application No. 111486,375. Confidential communications between and among Par attorneys and Par employees requesting, providing, containing, andor referring to legal advice regarding the preparation of U.S. Patent Application No. 111486,375. Confidential communications between and among Par attorneys and Par employees requesting, providing, containing, andor referring to legal advice regarding the preparation of U.S. Patent Application No. 111486,375. Confidential communications between and among Par attorneys and Par employees requesting, providing, containing, andor referring to legal advice regarding the preparation of U.S. Patent Application No. 111486,375. Confidential communications between and among Par attorneys and Par employees requesting, providing, containing, andor referring to legal advice regarding the preparation of U.S. Patent Application No. 111486,375. Confidential communications between and among Par attorneys and Par employees requesting, providing, containing, andor referring to legal advice regarding the preparation of U.S. Patent Application No. 111486,375. Confidential communications between and among Par attorneys and Par employees requesting, providing, containing, andor referring to legal advice regarding

AC

AC

AC

AC

AC

AC

AC

AC

Case 1:06-cv-00774-JJF

Document 217-2

Filed 04/04/2008

Page 40 of 90

DOC NO.

DOCUMENT TYPE

DATE

AUTHOR(S)

ADDRESSEE(S)

COPY RECIPIENT(S)

GENERAL SUBJECT MATTER

PRIVIL